What is CJC-1295 (no DAC)?
CJC-1295 without DAC is a synthetic analogue of Growth Hormone-Releasing Hormone (GHRH). It’s a peptide that mimics natural GHRH, stimulating the release of human growth hormone (hGH). This peptide is designed to replicate natural GHRH functions, thereby enhancing the body’s hGH production.
CJC-1295 without DAC is notable for its amino acid sequence of 29 amino acids. Its molecular structure, including amino acids like Lys, Asp, Ala, and Leu, allows effective binding to GHRH receptors. The absence of DAC gives it a shorter half-life, which is significant in its action compared to the longer-acting version with DAC.
How does CJC-1295 work?
CJC-1295 without DAC stimulates the production and release of growth hormone (GH) from the pituitary gland by binding to the growth hormone-releasing hormone receptor (GHRHR). It essentially instructs the pituitary gland to secrete more growth hormone, which is crucial for various bodily functions like cell repair, metabolism, and growth.
The action of CJC-1295 without DAC is characterized by its pulsatile nature, which promotes natural patterns of GH release. This is advantageous for maintaining bodily balance and optimizing the benefits of increased GH levels while minimizing potential side effects.
What are the benefits of CJC-1295?
- Increased Growth Hormone Secretion: Significantly boosts the production of growth hormone.
- Enhanced Muscle Growth: Facilitates muscle growth and development.
- Improved Recovery and Repair: Accelerates recovery times and enhances cellular repair mechanisms.
- Fat Reduction: Aids in reducing body fat.
- Increased Protein Synthesis: Enhances the body’s ability to synthesize proteins.
- Strengthened Immune System: Potentially improves immune system functionality.
CJC-1295 without DAC may also provide minor benefits like improved skin elasticity and bone density, attributed to enhanced growth hormone levels in the body.
What are the common side effects of CJC-1295?
Common side effects of CJC-1295 include injection site reactions, headaches, dizziness, nausea, and fluid retention.
What are common dosages and cycles for CJC-1295 while researched?
- Initial Dose: Typically starts at around 100 micrograms (mcg) per injection.
- Regular Dosing: Commonly, 100 to 200 mcg injected 2x/day.
- Cycle Length: Research cycles often vary, with common durations ranging from 8 to 12 weeks.
Research on CJC-1295 has demonstrated its effectiveness in stimulating growth hormone secretion and providing various health benefits. However, it’s important to note that these studies are in the context of research and not for human consumption, as CJC-1295 is not FDA-approved for clinical use.